HEADER SIGNALING PROTEIN 14-DEC-15 5FQS TITLE SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: TITLE 2 TETRAHYDROISOQUINOLINE PHENOLS 3. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, UNP RESIDUES 307-554; COMPND 5 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR COMPND 6 SUBFAMILY 3 GROUP A MEMBER 1, ESTROGEN RECEPTOR ALPHA; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD KEYWDS SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, KEYWDS 2 FULVESTRANT, THIQ, NUCLEAR HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SCOTT,A.BAILEY,R.D.M.DAVIES,S.L.DEGORCE,P.A.MACFAUL,H.GINGELL, AUTHOR 2 T.MOSS,R.A.NORMAN,J.H.PINK,A.A.RABOW,B.ROBERTS,P.D.SMITH REVDAT 2 12-OCT-16 5FQS 1 REMARK REVDAT 1 10-FEB-16 5FQS 0 JRNL AUTH J.S.SCOTT,A.BAILEY,R.D.M.DAVIES,S.L.DEGORCE,P.A.MACFAUL, JRNL AUTH 2 H.GINGELL,T.MOSS,R.A.NORMAN,J.H.PINK,A.A.RABOW,B.ROBERTS, JRNL AUTH 3 P.D.SMITH JRNL TITL TETRAHYDROISOQUINOLINE PHENOLS: SELECTIVE ESTROGEN RECEPTOR JRNL TITL 2 DOWNREGULATOR ANTAGONISTS WITH ORAL BIOAVAILABILITY IN RAT. JRNL REF ACS MED.CHEM.LETT. V. 7 94 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 26819673 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00413 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.M.WEIR,R.H.BRADBURY,M.LAWSON,A.A.RABOW,D.BUTTAR, REMARK 1 AUTH 2 R.J.CALLIS,J.O.CURWEN,C.DE ALMEIDA,P.BALLARD,M.HULSE, REMARK 1 AUTH 3 C.S.DONALD,L.J.L.FERON,G.KAROUTCHI,P.MACFAUL,T.MOSS, REMARK 1 AUTH 4 R.A.NORMAN,S.E.PEARSON,M.TONGE,G.DAVIES,G.E.WALKER,Z.WILSON, REMARK 1 AUTH 5 R.ROWLINSON,S.POWELL,C.SADLER,G.RICHMOND,B.LADD,E.PAZOLLI, REMARK 1 AUTH 6 A.M.MAZZOLA,C.D'CRUZ,C.DE SAVI REMARK 1 TITL AZD9496: AN ORAL ESTROGEN RECEPTOR INHIBITOR THAT BLOCKS REMARK 1 TITL 2 THE GROWTH OF ER-POSITIVE AND ESR1-MUTANT BREAST TUMORS IN REMARK 1 TITL 3 PRECLINICAL MODELS. REMARK 1 REF CANCER RES. V. 76 3307 2016 REMARK 1 REFN ISSN 0008-5472 REMARK 1 PMID 27020862 REMARK 1 DOI 10.1158/0008-5472.CAN-15-2357 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU, REMARK 3 STEINER,NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.91 REMARK 3 NUMBER OF REFLECTIONS : 20764 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.18605 REMARK 3 R VALUE (WORKING SET) : 0.18414 REMARK 3 FREE R VALUE : 0.22317 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 1120 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.937 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.987 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1481 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.74 REMARK 3 BIN R VALUE (WORKING SET) : 0.202 REMARK 3 BIN FREE R VALUE SET COUNT : 76 REMARK 3 BIN FREE R VALUE : 0.237 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1834 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 96 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.921 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.42 REMARK 3 B22 (A**2) : 0.42 REMARK 3 B33 (A**2) : -1.38 REMARK 3 B12 (A**2) : 0.42 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.142 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.136 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.089 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.070 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1918 ; 0.020 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1846 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2604 ; 1.841 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4234 ; 0.935 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 234 ; 5.130 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 79 ;36.307 ;24.304 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 342 ;13.706 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;22.366 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 306 ; 0.109 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2142 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 417 ; 0.001 ; 0.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 939 ; 2.071 ; 2.120 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 938 ; 2.067 ; 2.119 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1172 ; 2.843 ; 3.163 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2) : 1173 ; 2.843 ; 3.163 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 978 ; 3.340 ; 2.487 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2) : 947 ; 3.338 ; 2.509 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2) : 1390 ; 4.978 ; 3.621 REMARK 3 LONG RANGE B REFINED ATOMS (A**2) : 2228 ; 6.349 ;17.650 REMARK 3 LONG RANGE B OTHER ATOMS (A**2) : 2147 ; 6.300 ;17.438 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 307 A 545 REMARK 3 ORIGIN FOR THE GROUP (A): 12.7257 33.8697 69.5596 REMARK 3 T TENSOR REMARK 3 T11: 0.0091 T22: 0.0344 REMARK 3 T33: 0.0161 T12: -0.0156 REMARK 3 T13: 0.0069 T23: -0.0046 REMARK 3 L TENSOR REMARK 3 L11: 0.4991 L22: 0.4141 REMARK 3 L33: 0.5469 L12: -0.4494 REMARK 3 L13: -0.1501 L23: 0.2036 REMARK 3 S TENSOR REMARK 3 S11: -0.0049 S12: -0.0032 S13: 0.0316 REMARK 3 S21: -0.0043 S22: 0.0112 S23: -0.0264 REMARK 3 S31: -0.0421 S32: 0.0974 S33: -0.0063 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES WITH TLS ADDED REMARK 4 REMARK 4 5FQS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-DEC-15. REMARK 100 THE PDBE ID CODE IS EBI-65777. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20764 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.95 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9 REMARK 200 R MERGE (I) : 0.06 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.5 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M PCTP, PH 6.5 (0.04 M REMARK 280 SODIUM PROPIONATE, 0.02 M SODIUM CACODYLATE, 0.04 M REMARK 280 BIS-TRIS PROPANE), 22% PEG3350, 0.2M MGCL2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 183.82200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.91100 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 137.86650 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 45.95550 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 229.77750 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 183.82200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 91.91100 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 45.95550 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 137.86650 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 229.77750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 137.86650 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2014 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2022 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2090 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 338 REMARK 465 GLU A 339 REMARK 465 ALA A 340 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 ALA A 546 REMARK 465 HIS A 547 REMARK 465 ARG A 548 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 401 CD CE NZ REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 LYS A 481 CD CE NZ REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 LYS A 529 CG CD CE NZ REMARK 470 LYS A 531 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2A HIS A 501 NE2A HIS A 501 11555 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 341 CB SER A 341 OG 0.081 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 515 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 MET A 543 CG - SD - CE ANGL. DEV. = -13.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 534 120.18 76.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND ARE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): THESE HAVE BEEN REPOSITIONED REMARK 525 BY APPLYING THE SYMMETRY TRANSFORMATION INDICATED. REMARK 525 REMARK 525 M RES CSSEQI ORIGINAL COORDINATES SYMMETRY TRANS. DIST. REMARK 525 X Y Z REMARK 525 HOH A2061 29.560 33.533 74.847 011 655 2.65 REMARK 525 HOH A2020 27.193 23.874 74.121 011 655 3.15 REMARK 525 HOH A2054 31.642 25.958 64.955 011 655 2.88 REMARK 525 HOH A2070 0.647 37.679 54.883 011 555 3.44 REMARK 525 HOH A2055 27.596 25.005 52.150 005 565 2.65 REMARK 525 HOH A2089 -1.945 44.262 58.703 011 555 3.04 REMARK 525 HOH A2083 3.008 58.221 70.737 011 555 3.63 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE J0W A1546 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FQP RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 1. REMARK 900 RELATED ID: 5FQR RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 2. REMARK 900 RELATED ID: 5FQT RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 4. REMARK 900 RELATED ID: 5FQV RELATED DB: PDB REMARK 900 SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: REMARK 900 TETRAHYDROISOQUINOLINE PHENOLS 5. DBREF 5FQS A 307 554 UNP P03372 ESR1_HUMAN 307 554 SEQADV 5FQS SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 5FQS SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 5FQS SER A 536 UNP P03372 LEU 536 ENGINEERED MUTATION SEQRES 1 A 248 ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU SEQRES 2 A 248 LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP SEQRES 3 A 248 PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU SEQRES 4 A 248 LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE SEQRES 5 A 248 ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR SEQRES 6 A 248 LEU HIS ASP GLN VAL HIS LEU LEU GLU SER ALA TRP LEU SEQRES 7 A 248 GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU SEQRES 8 A 248 HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU SEQRES 9 A 248 ASP ARG ASN GLN GLY LYS SER VAL GLU GLY MET VAL GLU SEQRES 10 A 248 ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG SEQRES 11 A 248 MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SEQRES 12 A 248 SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SEQRES 13 A 248 SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE SEQRES 14 A 248 HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS SEQRES 15 A 248 LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS SEQRES 16 A 248 GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE SEQRES 17 A 248 ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER SEQRES 18 A 248 MET LYS CYS LYS ASN VAL VAL PRO SER TYR ASP LEU LEU SEQRES 19 A 248 LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SEQRES 20 A 248 SER HET J0W A1546 27 HETNAM J0W (E)-3-[4-(6-HYDROXY-2-ISOBUTYL-1-METHYL-3,4- HETNAM 2 J0W DIHYDROISOQUINOLIN-1-YL)PHENYL]PROP-2-ENOIC HETNAM 3 J0W ACID FORMUL 2 J0W C23 H27 N O3 FORMUL 3 HOH *96(H2 O) HELIX 1 1 THR A 311 GLU A 323 1 13 HELIX 2 2 SER A 341 ARG A 363 1 23 HELIX 3 3 GLY A 366 LEU A 370 5 5 HELIX 4 4 THR A 371 MET A 396 1 26 HELIX 5 5 ARG A 412 LYS A 416 1 5 HELIX 6 6 GLY A 420 MET A 438 1 19 HELIX 7 7 GLN A 441 SER A 456 1 16 HELIX 8 8 THR A 465 ALA A 493 1 29 HELIX 9 9 THR A 496 MET A 528 1 33 HELIX 10 10 SER A 536 ASP A 545 1 10 SHEET 1 AA 2 LYS A 401 ALA A 405 0 SHEET 2 AA 2 LEU A 408 ASP A 411 -1 O LEU A 408 N PHE A 404 SITE 1 AC1 10 THR A 347 ALA A 350 ASP A 351 GLU A 353 SITE 2 AC1 10 ARG A 394 PHE A 404 ILE A 424 VAL A 533 SITE 3 AC1 10 VAL A 534 HOH A2095 CRYST1 58.379 58.379 275.733 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017129 0.009890 0.000000 0.00000 SCALE2 0.000000 0.019779 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003627 0.00000